Affinity Biosensors
PrivateLast Round
Seed Round
Mar 23, 2026
Total Funding Raised
$7.38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Affinity Biosensors is a biotechnology company that develops and manufactures diagnostic instruments, including the LifeScale AST system for rapid antimicrobial susceptibility testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affinity Biosensors Comparables
Compare Affinity Biosensors with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gradientech | 91% | |
| SeLux Diagnostics | 86% | |
| FASTinov | 85% |
Affinity Biosensors Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 23, 2026 | ||||
| VC Round | Nov 17, 2021 | ||||
| VC Round | Jul 10, 2019 | ||||
| VC Round | Dec 19, 2018 | ||||
| VC Round | Jul 13, 2017 | ||||
VC Round | Jun 29, 2016 |
Affinity Biosensors Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rose Ventures Inc. | VC Round, Series A |
| National Institute of General Medical Sciences | Grant |
| Founders Capital Partners | VC Round, Series A |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 23, 2026
Raised $2M in seed funding.
- Jan 1, 2013
$150K grant from the National Science Foundation.
Affinity Biosensors Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Affinity Biosensors's valuation, stock price, and market status.
Is Affinity Biosensors a public or private company?
Affinity Biosensors is a private company.
What is the current stock price of Affinity Biosensors?
Affinity Biosensors is a private company with no public stock price. No recent secondary market data is available.
How much is Affinity Biosensors worth (valuation)?
Valuation information for Affinity Biosensors is not publicly available.
Can I buy Affinity Biosensors stock?
Affinity Biosensors shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Affinity Biosensors's last funding round?
Affinity Biosensors's most recent funding round was Seed Round on March 23, 2026.
Who are the main investors in Affinity Biosensors?
Key investors in Affinity Biosensors include Rose Ventures Inc., National Institute of General Medical Sciences, Founders Capital Partners, National Science Foundation.
Will Affinity Biosensors IPO soon?
No public IPO plans have been announced for Affinity Biosensors.
How can I track Affinity Biosensors secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Affinity Biosensors's secondary market activity and sign up for updates.